0
Skip to Content
Welcome to the Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels
Welcome to the Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Folder: RESOURCES
Back
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels

Oxford Drug Design awarded £1m to progress uUTI treatment

24 Feb
Written by Alexandra Collingbourne
Alexandra Collingbourne
Previous
Previous

Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial

Next
Next

FLIT to ramp up electric bike production as investors pump in £1.2m

LI-In-Bug_small.png

Privacy